Status:
COMPLETED
Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain
Lead Sponsor:
Seoul National University
Conditions:
Neuralgia
Neuralgia; Postherpetic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will evaluate the effectiveness and safety of acupuncture treatment in refractory neuropathic pain patients.
Detailed Description
The purpose of this study was to evaluate the effectiveness of acupuncture treatment in the patients with the following neuropathic pain related syndrome. * Postherpetic neuralgia * Failed back surge...
Eligibility Criteria
Inclusion
- Patients who can adequately write a reportable questionnaire
- Patients who have been diagnosed with one of the following neuropathic pain disease (postherpetic neuralgia, failed back surgery syndrome, diabetic neuropathy, other peripheral neuropathy)
- Patients who failed conservative treatment at Seoul National University Hospital for more than 3 months.
- Patients with NRS 5 points or more
- Patients with painDETECT score 19 points or more
Exclusion
- Patients with major mental illness
- Patients with unstable medical conditions
- Pregnant
- Patients who received acupuncture treatment at the site within the past month
- Patients with bleeding tendency
- Patients taking immunosuppressive drugs
Key Trial Info
Start Date :
May 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2018
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03315598
Start Date
May 15 2017
End Date
February 23 2018
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea